Annual Total Liabilities
$60.37 M
+$39.57 M+190.22%
31 December 2023
Summary:
Inozyme Pharma annual total liabilities is currently $60.37 million, with the most recent change of +$39.57 million (+190.22%) on 31 December 2023. During the last 3 years, it has risen by +$49.11 million (+436.13%). INZY annual total liabilities is now -25.62% below its all-time high of $81.16 million, reached on 31 December 2019.INZY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$60.57 M
-$719.00 K-1.17%
30 September 2024
Summary:
Inozyme Pharma quarterly total liabilities is currently $60.57 million, with the most recent change of -$719.00 thousand (-1.17%) on 30 September 2024. Over the past year, it has increased by +$15.08 million (+33.16%). INZY quarterly total liabilities is now -48.90% below its all-time high of $118.53 million, reached on 30 June 2020.INZY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +190.2% | +33.2% |
| 3 y3 years | +436.1% | +414.6% |
| 5 y5 years | +5.1% | - |
INZY Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +436.1% | -1.2% | +414.6% |
| 5 y | 5 years | -25.6% | +436.1% | -48.9% | +1133.9% |
| alltime | all time | -25.6% | +436.1% | -48.9% | +1133.9% |
Inozyme Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.57 M(-1.2%) |
| June 2024 | - | $61.29 M(+5.5%) |
| Mar 2024 | - | $58.11 M(-3.7%) |
| Dec 2023 | $60.37 M(+190.2%) | $60.37 M(+32.7%) |
| Sept 2023 | - | $45.49 M(+0.3%) |
| June 2023 | - | $45.34 M(+17.9%) |
| Mar 2023 | - | $38.45 M(+84.8%) |
| Dec 2022 | $20.80 M | $20.80 M(+8.1%) |
| Sept 2022 | - | $19.24 M(+50.2%) |
| June 2022 | - | $12.81 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.70 M(+3.0%) |
| Dec 2021 | $14.27 M(+26.8%) | $14.27 M(+21.2%) |
| Sept 2021 | - | $11.77 M(+17.9%) |
| June 2021 | - | $9.98 M(-0.4%) |
| Mar 2021 | - | $10.03 M(-11.0%) |
| Dec 2020 | $11.26 M(-86.1%) | $11.26 M(+1.7%) |
| Sept 2020 | - | $11.08 M(-90.7%) |
| June 2020 | - | $118.53 M(+2314.5%) |
| Mar 2020 | - | $4.91 M(-94.0%) |
| Dec 2019 | $81.16 M(+41.4%) | $81.16 M |
| Dec 2018 | $57.42 M | - |
FAQ
- What is Inozyme Pharma annual total liabilities?
- What is the all time high annual total liabilities for Inozyme Pharma?
- What is Inozyme Pharma annual total liabilities year-on-year change?
- What is Inozyme Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Inozyme Pharma?
- What is Inozyme Pharma quarterly total liabilities year-on-year change?
What is Inozyme Pharma annual total liabilities?
The current annual total liabilities of INZY is $60.37 M
What is the all time high annual total liabilities for Inozyme Pharma?
Inozyme Pharma all-time high annual total liabilities is $81.16 M
What is Inozyme Pharma annual total liabilities year-on-year change?
Over the past year, INZY annual total liabilities has changed by +$39.57 M (+190.22%)
What is Inozyme Pharma quarterly total liabilities?
The current quarterly total liabilities of INZY is $60.57 M
What is the all time high quarterly total liabilities for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total liabilities is $118.53 M
What is Inozyme Pharma quarterly total liabilities year-on-year change?
Over the past year, INZY quarterly total liabilities has changed by +$15.08 M (+33.16%)